Krystal Biotech, Inc.盘中异动临近午盘股价大涨5.07%报186.48美元

自选股智能写手06-12

北京时间2024年06月12日23时32分，Krystal Biotech, Inc.（KRYS.us）股票出现波动，股价大幅拉升5.07%。截至发稿，该股报186.48美元/股，成交量13.5835万股，换手率0.48%，振幅3.62%。最近的财报数据显示，该股实现营业收入45.25百万美元，净利润932000.00美元，每股收益0.03美元，毛利41.22百万美元，市盈率85.42倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2442456941?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-12 23:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2442456941","market":"us","top_or_hot":-1,"title":"Krystal Biotech, Inc.盘中异动 临近午盘股价大涨5.07%报186.48美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年06月12日23时32分，Krystal Biotech, Inc.（KRYS.us）股票出现波动，股价大幅拉升5.07%。截至发稿，该股报186.48美元/股，成交量13.5835万股，换手率0.48%，振幅3.62%。最近的财报数据显示，该股实现营业收入45.25百万美元，净利润932000.00美元，每股收益0.03美元，毛利41.22百万美元，市盈率85.42倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612233239941ee1e6&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Krystal Biotech, Inc.盘中异动 临近午盘股价大涨5.07%报186.48美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKrystal Biotech, Inc.盘中异动 临近午盘股价大涨5.07%报186.48美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-12 23:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612233239941ee1e6&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年06月12日23时32分，Krystal Biotech, Inc.（KRYS.us）股票出现波动，股价大幅拉升5.07%。截至发稿，该股报186.48美元/股，成交量13.5835万股，换手率0.48%，振幅3.62%。最近的财报数据显示，该股实现营业收入45.25百万美元，净利润932000.00美元，每股收益0.03美元，毛利41.22百万美元，市盈率85.42倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612233239941ee1e6&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KRYS","symbol_name":"Krystal Biotech Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612233239941ee1e6&s=b","article_id":"2442456941","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612233239941ee1e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2442456941","pubTimestamp":1718206358,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年06月12日23时32分，Krystal Biotech, Inc.股票出现波动，股价大幅拉升5.07%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。消息层面，截至23时32分，《Form 144 | Krystal Biotech董事拟出售2.5万股股份，价值约442.08万美元》资讯为影响Krystal Biotech, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间6月11日披露的文件，$Krystal Biotech $董事SUMA KRISHNAN拟于6月11日出售2.5万股普通股股份，总市值约442.08万美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"KRYS":"Krystal Biotech Inc.","BK4139":"生物科技","LGVN":"Longeveron Inc"},"translate_title":"Krystal Biotech, Inc. 's stock price rose 5.07% to $186.48 near midday","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KRYS":0.9,"LGVN":0.9},"content_text":"北京时间2024年06月12日23时32分，Krystal Biotech, Inc.（KRYS.us）股票出现波动，股价大幅拉升5.07%。截至发稿，该股报186.48美元/股，成交量13.5835万股，换手率0.48%，振幅3.62%。最近的财报数据显示，该股实现营业收入45.25百万美元，净利润932000.00美元，每股收益0.03美元，毛利41.22百万美元，市盈率85.42倍。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Krystal Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 (To Pur Com)、Longeveron Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)涨幅较大，Longeveron Inc.、Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.较为活跃，换手率分别为116.71%、95.42%、33.06%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)、Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Longeveron Inc.，振幅分别为85.53%、76.92%、68.40%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。 它专注于开发易使用、可重复治疗的基因疗法，从而改善患有衰弱性疾病的患者的生活。该公司使用其专有的基因治疗平台 STAR-D 开发针对由单个基因缺失或突变引起的罕见或孤儿皮肤病适应症的治疗方法。该公司计划通过其平台扩大其产品线，以包括未来的其他皮肤科适应症。 该公司有一个经营部门，即药品开发和商业化业务。消息层面，截至23时32分，《Form 144 | Krystal Biotech(KRYS.US)董事拟出售2.5万股股份，价值约442.08万美元》资讯为影响Krystal Biotech, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会（SEC）美东时间6月11日披露的文件，Krystal Biotech 董事SUMA KRISHNAN拟于6月11日出售2.5万股普通股股份，总市值约442.08万美元。其中，关联方必须持有证券至少六个月，卖出的股数不得超过已发行股份总数的1%。关联方在任何三个月期间出售的股票数量超过5,000股时，或总市值超5万美元时须向SEC提交该表格。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2442456941"}

Krystal Biotech, Inc.盘中异动 临近午盘股价大涨5.07%报186.48美元

精彩评论

Krystal Biotech, Inc.盘中异动临近午盘股价大涨5.07%报186.48美元